NDC 0024-0674 – Sarclisa Escena
Isatuximab 140 mg/mL · Injection, Solution · Subcutaneous
Product NDC0024-0674
Product details
- Brand name
- Sarclisa Escena
- Generic name
- Isatuximab-irfc
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761445
- Marketed since
- July 9, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD38-directed Cytolytic Antibody
Active ingredients
- Isatuximab 140 mg/mL
Uses, dosage, side effects and warnings for Sarclisa Escena →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0024-0674-01 | 1 VIAL in 1 CARTON (0024-0674-01) / 10 mL in 1 VIAL | Jul 9, 2026 |